BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Shareholder Equity 2023–2025
BridgeBio Oncology Therapeutics, Inc. annual shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BridgeBio Oncology Therapeutics, Inc. shareholder equity as of December 31, 2025: 411.1M, a 330.13% decrease year-over-year.
- BridgeBio Oncology Therapeutics, Inc. shareholder equity for 2025 were 411.1M, a 330.13% decrease from 2024.
- BridgeBio Oncology Therapeutics, Inc. shareholder equity for 2024 were -178.6M, a 54.48% increase from 2023.
- BridgeBio Oncology Therapeutics, Inc. shareholder equity for 2023 were -115.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Oncology Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $411 |
| 2024 | $-179 |
| 2023 | $-116 |
BridgeBio Oncology Therapeutics, Inc. Shareholder Equity — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's shareholder equity history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.